test
Author: Admin
Developer
test article
BACK TO THE ROCK. NobleCon16
Noble Capital Markets’ sixteenth annual emerging growth investor conference.
Seminole Hard Rock Hotel & Casino. Hollywood Florida. February 16-18, 2020.
Be among the first to experience the new flagship Hard Rock. The $1.5 billion triple-its-size expansion will be ready and open this winter. The host hotel of Super Bowl LIV (and, by-the-way, the game is played at Hard Rock Stadium). The NFL 100th anniversary party. And NobleCon16. Spanning 200-plus acres, the new luxury Hard Rock Hollywood will offer 1267 rooms including 638 in the first-of-its-kind Guitar Tower reaching 450 feet into the sky; 36 restaurants, bars and lounges; 6,500-seat all-new Hard Rock Live world-class entertainment venue, 42,000 square foot Oasis Spa; 200,000 square feet of gaming, and; multiple resort pools covering close to 20 acres (one of which is the size of three football fields). And where is this new icon of the South Florida skyline? Less than 15 minutes from Fort Lauderdale / Hollywood International Airport. Uber: about 10 bucks.
It’s big but you won’t have a problem finding us – we’re taking over 40,000 square feet of the new-construction state-of-the art conference facility. Hard Rock hosted our first NobleCon fifteen years ago. NobleCon six though nine as well. Their 2020 vision, once again, aligns perfectly with ours. This is the place to work hard and play hard. NobleCon16. The ultimate adventure in capitalism.
Comtech (CMTL) – Can the Current Upswing be Maintained?
Friday, June 7, 2019
Comtech Telecommunications (CMTL)
Will a Strong FY2019 Translate into an Even Better FY2020?
Comtech Telecommunications Corp. engages in the design, development, production, and marketing of products, systems, and services for advanced communications solutions in the United States and internationally. It operates in three segments: Telecommunications Transmission, Mobile Data Communications, and RF Microwave Amplifiers.
Joe Gomes, Senior Research Analyst, Noble Capital Markets, Inc.
Refer to full report for price target, fundamental analysis and rating.
Solid Quarter, Stock Reacts Positively. Comtech reported strong 3Q19 results, as we highlighted in our June 5, 2019 report. Unlike following the 2Q release, CMTL shares reacted positively to the 3Q news, rising as much as 21% yesterday before closing up nearly 17%.
Strength Across the Board.Comtech is seeing positive business momentum nearly across the board…
Get full report on Channelchek desktop.
*Analyst
certification and important disclosures included in full report.
NOTE: investment decisions should not be based upon the content of
this research summary. Proper due diligence is required before
making any investment decision.
News – A Chimera Becomes a Novel Cancer Treatment (Part 1)
CAR-T and the Possibility of Cancer Treatment, Part 1
style=”margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: Calibri, sans-serif;”>click her for part two of this article series
(Note: companies that could be impacted by the content of this article are listed at the base of the story (desktop version). This article uses third-party references to provide a bullish, bearish and balanced point of view; sources listed in the “Balanced” section)
Chimeric Antigen
Receptor T cell therapy (CAR-T) is a gene therapy designed to harness the
potency of antibodies and T-lymphocytes into one single medicine for the
treatment of cancer. CAR-T therapy could be viewed as a “living anti-cancer
drug” as the medicine itself consists of a living cell, which is genetically
engineered to find and destroy cancer cells. Dr. Carl H. June pioneered this
technology at the University of Pennsylvania, where the first tests were
conducted in cancer patients in 2010. Seven years later, the U.S. Food &
Drug Administration (FDA) approved this novel gene therapy for the treatment of
patients suffering from “B-cell precursor acute lymphoblastic leukemia” (ALL),
a type of blood cancer known to be the most common malignant growth in
children.
Thus far, anti-cancer
antibodies have been one of the most successful drug classes for the treatment
of cancer patients. Antibody drugs such as Roche’s Avastin, Herceptin and Rituxan have prolonged survival of many
cancer patients. Another class of medicines, known as T-infiltrating
lymphocytes (TILs), has been shown to be effective as an anti-cancer treatment.
Given the relative success of both therapeutic strategies, the question is, how
do you combine both treatments into one potent anti-cancer drug?
CAR-T represents
the solution to this riddle. CAR-T consists of two main components: 1) the
tumor associated antigen (TAA) domain of an anti-cancer antibody (scFV) linked through
a spacer/transmembrane region to 2) the cytoplasmic domain of the receptor of a
cancer-killing T lymphocyte. The new anti-cancer drug, CAR-T, is a genetically
engineered T-lymphocyte expressing a chimeric T cell receptor on its surface
(Figure 1). This chimera consists of the binding domain of the antibody
(external domain protruding from the cell surface), fused to the signaling portion
CD3 of the T cell receptor (internal domain facing the cellular cytoplasm).
Figure 1 – Structure of a CAR-T construct. The left panel depicts a
CAR-T medicine (first generation), whereas the right panel depicts the natural
T cell receptor, TCR. In the CAR-T construct (left panel), the binding domain
(light blue/purple) of an anti-cancer antibody (scFV) replaces the alpha/beta
chain portion (green/red) of the natural TCR (right panel). The transmembrane
and cytoplasmic components of CAR-T and TCR, including CD3 domain, are depicted
in blue.
Source – Oncotarget 2015,
8(52)90521-90531 ?
To generate a
CAR-T drug, five main steps are required (Figure 2):
- blood from the patient is extracted
- T-lymphocytes are purified from extracted
blood, and subsequently genetically modified to express the CAR chimeric
receptor - CAR-T cells are grown in vitro (ex vivo)
- Once CAR-T cells are grown to reach a
therapeutic dose, they are injected back into the patient - Injected CAR-T cells are engineered to find
and kill cancer cells
Source – The University of Texas
Southwestern Medical Center
Research – Comtech (CMTL) – Q3 Delivers Record Backlog
Thursday, June 6, 2019
Comtech Telecommunications (CMTL)
Can Comtech Continue the Positive Momentum?
Comtech Telecommunications Corp. engages in the design, development, production, and marketing of products, systems, and services for advanced communications solutions in the United States and internationally. It operates in three segments: Telecommunications Transmission, Mobile Data Communications, and RF Microwave Amplifiers.
Joe Gomes, Senior Research Analyst, Noble Capital Markets, Inc.
Refer to full report for price target, fundamental analysis and rating.
Strong 3Q19 Results. Comtech reported revenue of $170.4 million, adjusted EBITDA of $24 million, GAAP EPS of $0.31, and non-GAAP EPS of $0.42. We were at $163 million, $20.3 million, and $0.21, respectively. Results exceeded management’s expectations. Significantly, business momentum remains positive and the pipeline of opportunities is strong.
Record Backlog.Comtech ended the third quarter with record backlog of $747.1 million. Comtech’s 3Q book-to-bill was 1.94, reflecting strength in…
Get full report on Channelchek desktop.
*Analyst
certification and important disclosures included in full report.
NOTE: investment decisions should not be based upon the content of
this research summary. Proper due diligence is required before
making any investment decision.
Research – electroCore (ECOR) – Departing Founder and Chief Science and Strategy Officer
Wednesday June 5, 2019
electroCore (ECOR)
Continuing Execution of the Redeployment Plan
Electrocore Inc is a commercial-stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology and rheumatology. Its product gammaCore is FDA-cleared for the acute treatment of pain associated with migraine and episodic cluster headache in adults.
Ahu Demir, Ph.D., Biotechnology Research Analyst, Noble Capital Markets, Inc.
Refer to full report for price target, fundamental analysis and rating.
Founder and Chief Science and Strategy Officer departs. electroCore announced another event as part of the redeployment plan that emerged on May 29. Founder Joseph P. Enrico, who served as the Company’s Chief Science and Strategy Officer, agreed to leave the company, effective as of June 8, 2019. He co-founded the company in 2005 and served in multiple roles including Chief Executive Officer (CEO) prior taking his current role in 2016. He remains as a Board Director and holds 2.2% equity stake in the company.
Chief Medical Officer to take over the strategy role. Management stated plans to continue with the current leadership team. Tony Fiorino, M.D. Ph.D. will continue to serve as Chief…
Get full report on Channelchek desktop.
*Analyst
certification and important disclosures included in full report.
NOTE: investment decisions should not be based upon the content of
this research summary. Proper due diligence is required before
making any investment decision.
Research – Kratos (KTOS) – Price Appreciation Pushes to Market Perform
Wednesday June 5, 2019
Kratos Defense & Security Solutions (KTOS)
Lowering Rating to Market Perform from Outperform on Price Appreciation
Kratos Defense & Security Solutions, Inc. provides engineering, information technology (IT) services, and warfighter solutions primarily in the United States. It operates in two segments, Kratos Government Solutions (KGS) and Public Safety and Security (PSS).
Joe Gomes, Senior Research Analyst, Noble Capital Markets, Inc.
Refer to full report for price target, fundamental analysis and rating.
Downgrading to Market Perform.We are lowering our rating to Market Perform from our previous Outperform as KTOS shares have topped our $20.00 12-month price target. We continue to believe in the long run potential of the Company but believe the shares may have gotten ahead of actual operating performance.
Significant Price Appreciation YTD. Since the beginning of the year, KTOS shares have appreciated 63.1%, well in excess of the Russ…
Get full report on Channelchek desktop.
*Analyst
certification and important disclosures included in full report.
NOTE: investment decisions should not be based upon the content of
this research summary. Proper due diligence is required before
making any investment decision.
News – Tariffs Make a Run for the Border
Is Trump’s Tough Talk on Mexico Tariffs Just a Publicity Stunt?
(Note: companies that could be impacted by the content of this article are listed at the base of the story (desktop version). This article uses third-party references to provide a bullish, bearish and balanced point of view; sources listed in the “Balanced” section)
On May 30, President Trump threatened the imposition of tariffs on Mexican imports to the United States. President Trump announced that a 5% tariff could take effect June 10. The tariff would increase to 10% on July 1 and increase by 5% each month until it reaches 25% on October 1, 2019. Trump, increasingly frustrated with migrants from Central America reaching the U.S. border, wants Mexico to do more to enforce its southern border. Given the economic stakes for both countries, it is likely that an agreement may be reached between the United States and Mexico before tariffs are imposed. What are the pros and cons of implementing tariffs on imports from Mexico?
Research – Aurania Resources (ARU.V) – Copper Exploration Yields Encouraging Results
Friday, May 31, 2019
Aurania Resources Ltd. (ARU:CA)
Adding To The Narrative …Above and Beyond The Lost Cities
Aurania Resources Ltd. is a Canada-based junior mining exploration company engaged in the identification, evaluation, acquisition, and exploration of mineral property interests, with a focus on precious metals and copper. Its flagship asset, The Lost Cities-Cutucu Project, is in southeastern Ecuador in the Province of Morona-Santiago. The company also has several minor projects in Switzerland.
Mark Reichman, Senior Research Analyst, Noble Capital Markets, Inc.
Refer to full report for price target, fundamental analysis and rating.
New copper-silver exploration concept. To date, Aurania’s copper exploration efforts have yielded encouraging results. While exploration has provided evidence of mineralized porphyries, management has been pleasantly surprised by evidence of sediment-hosted copper-silver deposits, traced over 22 kilometers. In our view, these findings could generate interest among major copper-oriented mining companies.
Updating estimates. Aurania recently filed its first quarter 2019 financial results. We are increasing our full year 2019 and 2020 loss per share estimates to ($0.39) and ($0.44) from ($0.36) and ($0.42), respectively. Our revisions reflect modestly higher operating costs. As an early-stage exploration company, Aurania does not generate revenues.
Get full report on Channelchek desktop.
*Analyst
certification and important disclosures included in full report.
NOTE: investment decisions should not be based upon the content of
this research summary. Proper due diligence is required before
making any investment decision.
Research – electroCore (ECOR) – Plans to Remove Headwinds
Friday, May 31, 2019
electroCore (ECOR)
Can the Reduced Cash Burn Calm Ragged Nerves?
Electrocore Inc is a commercial-stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology and rheumatology. Its product gammaCore is FDA-cleared for the acute treatment of pain associated with migraine and episodic cluster headache in adults.
Ahu Demir, Ph.D., Biotechnology Research Analyst, Noble Capital Markets, Inc.
Refer to full report for price target, fundamental analysis and rating.
- Concern around the high cash burn is lowered. electroCore implemented a cost reduction and deployment plan reducing the cash burn to $2.3 million from $4 million per month, effective by June 2019. We view extension of the cash runaway as a positive road map for the company, but we believe the stock will remain under pressure until the company shows a solid revenue ramp-up.
- Basis of the cost reduction plan. The cost reduction was endowed by i) reducing work force to 55 positions from 91 – eliminating sales, medical affairs personnel, ii) abolishing cash compensation of board servicing by independent directors, iii) voluntary acceptance of stock compensation in lieu of cash compensation by Chief Executive Officer Francis Amato and iv) postponing current clinical operations – to be determined following the company’s board meeting on June.
Get full report on Channelchek desktop.
*Analyst
certification and important disclosures included in full report.
NOTE: investment decisions should not be based upon the content of
this research summary. Proper due diligence is required before
making any investment decision.
News – The Great Debate: Active or Passive Management?
Active vs Passive Investing: Is there Still a Place for Stock Pickers?
(Note: companies that could be impacted by the content of this article are listed at the base of the story (desktop version). This article uses third-party references to provide a bullish, bearish and balanced point of view; sources listed in the “Balanced” section)
At some point in 2019, the market share of passive funds will top 50%, marking an inflection point in the active versus passive debate. Since the end of 2006, investors have withdrawn approximately $1.2 trillion from actively managed U.S. equity mutual funds and have allocated some $1.4 trillion to U.S. equity index funds and exchange traded funds (ETFs). At the end of 2018, mutual funds and ETFs that passively track indexes held 48% of market assets. By definition, active portfolio management focuses on outperforming the market compared to a specific benchmark, while passive portfolio management aims to mimic the investment holdings of a particular index. But, as we shall see, the line between passive and active investing is not black and white.
Research – Euroseas (ESEA) – Price Target Revision
Thursday, May 30, 2019
Euroseas Ltd. (ESEA)
Heading for a Rebound?
Euroseas Ltd. provides ocean-going transportation services worldwide. The company owns and operates containerships that transport dry and refrigerated containerized cargoes, including manufactured products and perishables; and drybulk carriers that transport iron ore, coal, grains, bauxite, phosphate, and fertilizers.
Poe Fratt, Senior Research Analyst, Noble Capital Markets, Inc.
Refer to full report for price target, fundamental analysis and rating.
- Quarterly results up sequentially due to stabilizing container market. Excluding drydock expenses, adjusted EBITDA was $2.0 million was line with our estimate of $2.1 million and sequentially above 4Q2018 adjusted EBITDA of $1.6 million, mainly due to slightly higher time equivalent (TCE) rates.
- Fine-tuning 2019 EBITDA estimate to reflect quarterly results and market improvement later this year. We estimate adjusted EBITDA of $9.4 mill…
Get full report on Channelchek desktop.
*Analyst
certification and important disclosures included in full report.
NOTE: investment decisions should not be based upon the content of
this research summary. Proper due diligence is required before
making any investment decision.
News – Will electric cars stall the demand for oil?
Does a green light for electric cars mean a red light for oil?
(Note: companies that could be impacted by the content of this article are listed at the base of the story (desktop version). This article uses third-party references to provide a bullish, bearish and balanced point of view; sources listed in the “Balanced” section)
Electric cars are no longer a novelty. There were more than 5.4 million electric vehicles (EVs) as of January 1, 2019, including hybrids. China represents more than half of the market followed by the US, Norway, Germany and the UK. The number of electric vehicles grows by more than 50% each year and the growth rate has shown no signs of slowing down. Every electric vehicle purchased means less demand for gasoline and thus oil. While it is true that oil is used to generate electricity, oil’s market share of generation is small and decreasing. It is reasonable to ask then, “will electric vehicle growth dampen the demand for oil and cause downward pressure on oil prices?”